Mumbai-headquartered drug firm, Ajanta Pharma has launched blood pressure lowering tablet in the US market. The medicine has been launched in four strengths 5mg+20mg, 5mg+40mg, 10mg+20mg and 10mg+40mg. The launch is part of growing portfolio of products that the company has developed for the US market.
Company said, after the approval of the United States Food and Drug Administration (USFDA), the company has launched Amlodipine + Olmesartan Medoxomil tablets in the US market through its arm Ajanta Pharma USA Inc.
The company’s product is a generic version of Daiichi Sankyo Inc’s Azor tablets, it added.
In total, the company has 29 Abbreviated New Drug Applications (ANDA) of which 16 are final ANDA app.